Lash Group and Xcenda Co-present Poster Presentation at ASH
Lash Group is excited to participate in the ASH 58th Annual Meeting & Exposition in San Diego, December 3-6, 2016. This conference is the world's premier event in malignant and non-malignant hematology. The meeting provides an invaluable educational experience and an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Attendees have the opportunity to network with top minds in the field, as well as a global community of more than 20,000 hematology professionals from every subspecialty.
To be a participant in this event, companies must submit research abstracts for acceptance for presentation. Lash Group, along with sister company Xcenda, presented a poster entitled “Impact of a Patient-Centered Support Program on Treatment Compliance Among Patients with Multiple Myeloma”, which talks to the positive impact a patient-centered program can have on IV therapy compliance among patients with multiple myeloma.